Bioanalytical and Theoretical Studies of the Spectrophotometrically Investigated Iridium (III)-3-Hydroxy-2-(4-Methoxyphenyl)-4H-Chromen-4-one Complex

被引:0
作者
Mohmad, Masrat [1 ]
Agnihotri, Nivedita [1 ]
Kumar, Vikas [2 ]
Sharma, Ujjawal [3 ]
Omkar, Raj Kamal [4 ]
Javed, Saleem [5 ]
Muthu, S. [6 ]
机构
[1] Maharishi Markandeshwar Deemed Univ, Dept Chem, Mullana 13320, Ambala, India
[2] Maharishi Markandeshwar Deemed Univ, Dept Biotechnol, Mullana 133207, Ambala, India
[3] Cent Univ Punjab, Sch Hlth Sci, Dept Human Genet & Mol Med, Bathinda 151401, India
[4] Kurukshetra Univ, Dept Chem, Kurukshetra 136119, India
[5] Dr Bhimrao Ambedkar Univ, Inst H Sci, Dept Chem, Agra 282002, Uttar Pradesh, India
[6] Aringnar Anna Govt Arts Coll, Dept Phys, Cheyyar 604407, India
来源
IRANIAN JOURNAL OF CHEMISTRY & CHEMICAL ENGINEERING-INTERNATIONAL ENGLISH EDITION | 2023年 / 42卷 / 10期
关键词
Iridium; Spectrophotometric determination; DFT; Anticancer; Antibacterial; Antioxidant; INDICATOR; OXIDATION; RHODIUM; AGENTS;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A pioneering approach for the spectrophotometric inquisition of microscale amounts of iridium (III) under aqueous conditions has been explored using a novel benzopyran derivative, 3-hydroxy-2-(4-methoxyphenyl)-4H-chromen-4-one (HMPC) as a ligand, hence, employing complexation as a basis of reaction between the two. The spontaneous complexation between iridium (III) and HMPC is manifested by the expeditious formation of a pale yellow complex at pH 4.87 in which the metal to ligand ratio [M:L] is estimated as 1:2. The complex absorbs paramountly at 423-430 nm and is markedly stable. For ensuring the formation of a stable complex, optimal conditions have been fixed with reference to the parameters regulating its formation. Accordingly, the system shows coherence to linearity between 0.0-1.7 mu g/mL of iridium (III). The molar attenuation coefficient and Sandell's sensitivity are 6.824x10(4) L/mol cm and 0.00281 mu g Ir (III) cm(-2), respectively at 425 nm. Statistical parameters including RSD, correlation coefficient (r), and detection limit are respectively, 0.2169%, 0.9999, and 0.0123 mu g/mL. As a check for flexibility and usability of the method, intervention concerning complexing agents and cations of prime analytical importance has been carried out indicating the majority of these do not induce any interference during determination. The accomplished studies serve as proof of the versatility, flexibility, and sensitivity of the method. Keeping in view the aforesaid characteristics of the complex, it was subjected to numerous biological investigations and has been satisfyingly found to possess anti -cancerous, bactericidal, and antioxidant properties thus expanding its novel utility domain in the therapeutic world. Quantum chemical parameters (DFT and MEP), based on analysis of electronic properties of the complex in its most stable least energy conformation, are used to better understand the chemistry of the produced complex.
引用
收藏
页码:3383 / 3398
页数:16
相关论文
共 50 条
  • [21] Synthesis and characterization of terbium(III) complexes with the biscoumarin derivative 3,3′-[(4-hydroxyphenyl)methyl]bis-(4-hydroxy-2H-chromen-2-one)
    Elenkova, D.
    Monov, R.
    Tadjer, A.
    Manolov, A.
    Milanova, M.
    JOURNAL OF MOLECULAR STRUCTURE, 2016, 1106 : 491 - 500
  • [22] Experimental and theoretical studies of (E)-2-(2-hydroxystyryl)-6-(4-methoxybenzoyl)-5-(4-methoxyphenyl)-1,2,4-triazin-3(2H)-one
    Ceylan, Umit
    Haciyusufoglu, Mehmet Emin
    Sonmez, Mehmet
    Yalcin, Serife Pinar
    Ozdemir, Namik
    SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY, 2015, 141 : 307 - 315
  • [23] Crystal structure of 3-(1,3-dinitropropan-2-yl)-4H-chromen-4-one, C12H10N2O6
    Li, Wu-Wu
    Zheng, Min-Yan
    Han, Ning-Ning
    Yang, Meng
    Li, Jiao
    Cao, Sha-Sha
    ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2022, 237 (05): : 939 - 940
  • [24] 5-Acetyl-4-(4-methoxyphenyl)-6-methyl-3,4-dihydropyrimidin-2(1H)-one
    Chitra, S.
    Pandiarajan, K.
    Anuradha, N.
    Thiruvalluvar, A.
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2009, 65 : O23 - U1474
  • [25] Enantiomeric separation of novel anticancer agent 5-hydroxy-3-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)-cyclopent-2-en-1-one
    Shinde, Popat D.
    Jadhav, Vinod H.
    Borate, Hanumant B.
    Bhide, Sunil R.
    Sonawane, Kiran B.
    Wakharkar, Radhika D.
    JOURNAL OF CHROMATOGRAPHY A, 2007, 1138 (1-2) : 184 - 189
  • [26] Biological evaluation of 2-(3,4-dihydroxyphenyl)-4-((4-methoxyphenyl) imino)-4H-chromene-3,5,7-triol: Design, synthesis, and molecular docking studies
    Rajesh, R. Udaya
    Sangeetha, Dhanaraj
    BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY, 2025, 63
  • [27] Experimental and computational studies of 3-(N-morpholinylcarbodithioate)-2-(4-methoxyphenyl)chroman-4-one, a flavanone with potential therapeutical properties
    Gosav, Steluta
    Praisler, Mirela
    Cristea, Nicoleta Paduraru
    Gosav, Teodora
    Paraschiv, Cristina
    JOURNAL OF MOLECULAR STRUCTURE, 2024, 1295
  • [28] (E)-1-(4-Methoxyphenyl)-3-(2,4,6-trimethoxyphenyl)prop-2-en-1-one
    Cai, Yuepiao
    Wang, Zhankun
    Li, Zhe
    Zhang, Meiling
    Wu, Jianzhang
    ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE, 2011, 67 : O1432 - U853
  • [29] DESIGN, SYNTHESIS AND ANTICANCER ACTIVITY OF SOME NOVEL 5-(4-METHOXYPHENYL)-2,4-DIHYDRO-3H-PYRAZOL-3-ONE DERIVATIVES
    Fathy, Usama
    Gouhar, Rasha S.
    Awad, Hanem M.
    ACTA POLONIAE PHARMACEUTICA, 2017, 74 (05): : 1427 - 1436
  • [30] Spectral characterizations, Hirshfeld surface analysis and molecular docking studies of new novel NLO 2-(3,4-Dimethoxyphenyl)-3-hydroxy-4H-chromen-4-one
    Parimala, K.
    INDIAN JOURNAL OF CHEMICAL TECHNOLOGY, 2023, 30 (03) : 278 - 292